Literature DB >> 21036613

Synthesis and in vitro inhibitory activity of matrine derivatives towards pro-inflammatory cytokines.

Honggang Hu1, Shaozhan Wang, Chunmei Zhang, Liang Wang, Li Ding, Junping Zhang, Qiuye Wu.   

Abstract

Matrine, a sophora alkaloid, exhibited good anti-inflammation effects in our previous report. In the present study, a series of matrine derivatives were synthesized via classical Michael addition. Biological studies showed that the synthetic derivatives had good inhibitory effect towards TNF-α production and NFκB transcriptional activity. The introduction of various amino groups to the keto beta position could improve the biochemical profile, resulting in the identification of more potent derivates, such as 1f, with higher inhibitory activity than both matrine and sophoramine.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036613     DOI: 10.1016/j.bmcl.2010.09.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.

Authors:  Ying Liu; Yang Qi; Zhi-Hui Bai; Chen-Xu Ni; Qi-Hui Ren; Wei-Heng Xu; Jing Xu; Hong-Gang Hu; Lei Qiu; Jian-Zhong Li; Zhi-Gao He; Jun-Ping Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-10-24       Impact factor: 6.150

2.  Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo.

Authors:  Yu-Shen Yang; Dan Wen; Xue-Feng Zhao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

3.  A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats.

Authors:  Yang Xu; Zhangxiao Peng; Weidan Ji; Xiang Li; Xuejing Lin; Liqiang Qian; Xiaoya Li; Xiaoyun Chai; Qiuye Wu; Quangen Gao; Changqing Su
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

4.  Matrine inhibits the migratory and invasive properties of nasopharyngeal carcinoma cells.

Authors:  Bin Sun; Min Xu
Journal:  Mol Med Rep       Date:  2015-01-29       Impact factor: 2.952

5.  Therapeutic effects of matrine derivate MASM in mice with collagen-induced arthritis and on fibroblast-like synoviocytes.

Authors:  Yuming Zou; Quan Li; Denghui Liu; Jia Li; Qing Cai; Chao Li; Qingjie Zhao; Weidong Xu
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

6.  WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.

Authors:  Chen-Xu Ni; Yang Qi; Jin Zhang; Ying Liu; Wei-Heng Xu; Jing Xu; Hong-Gang Hu; Qiu-Ye Wu; Yan Wang; Jun-Ping Zhang
Journal:  Oncotarget       Date:  2016-11-29

7.  Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis.

Authors:  Xiao Chen; Xin Zhi; Liehu Cao; Weizong Weng; Panpan Pan; Honggang Hu; Chao Liu; Qingjie Zhao; Qirong Zhou; Jin Cui; Jiacan Su
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

8.  Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells.

Authors:  Yi Feng; Hai-Yan Ying; Ying Qu; Xiao-Bo Cai; Ming-Yi Xu; Lun-Gen Lu
Journal:  Protein Cell       Date:  2016-06-24       Impact factor: 14.870

9.  Synthesis, characterization and in vitro biological evaluation of two matrine derivatives.

Authors:  Xingan Cheng; Jingmin Ye; Huiqing He; Zhanmei Liu; Chunbao Charles Xu; Bo Wu; Xialing Xiong; Xugang Shu; Xuhong Jiang; Xiangjing Qin
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

10.  Synthesis, characterization and activity evaluation of matrinic acid derivatives as potential antiproliferative agents.

Authors:  Fan Chao; Dong-En Wang; Rui Liu; Qin Tu; Jian-Jun Liu; Jinyi Wang
Journal:  Molecules       Date:  2013-05-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.